These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25881828)

  • 1. ABL kinase inhibitory and antiproliferative activity of novel picolinamide based benzothiazoles.
    El-Damasy AK; Cho NC; Kang SB; Pae AN; Keum G
    Bioorg Med Chem Lett; 2015; 25(10):2162-8. PubMed ID: 25881828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of new benzothiazole-based inhibitors of breakpoint cluster region-Abelson kinase including the T315I mutant.
    Hong S; Kim J; Yun SM; Lee H; Park Y; Hong SS; Hong S
    J Med Chem; 2013 May; 56(9):3531-45. PubMed ID: 23600806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HS-438, a new inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.
    Yun SM; Jung KH; Kim SJ; Fang Z; Son MK; Yan HH; Lee H; Kim J; Shin S; Hong S; Hong SS
    Cancer Lett; 2014 Jun; 348(1-2):50-60. PubMed ID: 24657654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives.
    El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G
    Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-Raf(V600E) and C-Raf kinase inhibitory activities.
    El-Damasy AK; Lee JH; Seo SH; Cho NC; Pae AN; Keum G
    Eur J Med Chem; 2016 Jun; 115():201-16. PubMed ID: 27017549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a Nanomolar Multikinase Inhibitor (KST016366): A New Benzothiazole Derivative with Remarkable Broad-Spectrum Antiproliferative Activity.
    El-Damasy AK; Cho NC; Nam G; Pae AN; Keum G
    ChemMedChem; 2016 Aug; 11(15):1587-95. PubMed ID: 27405013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of novel water-soluble triptolide derivatives: Antineoplastic activity against imatinib-resistant CML cells bearing T315I mutant Bcr-Abl.
    Xu F; Shi X; Li S; Cui J; Lu Z; Jin Y; Lin Y; Pang J; Pan J
    Bioorg Med Chem; 2010 Mar; 18(5):1806-15. PubMed ID: 20149665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.
    Mortimer CG; Wells G; Crochard JP; Stone EL; Bradshaw TD; Stevens MF; Westwell AD
    J Med Chem; 2006 Jan; 49(1):179-85. PubMed ID: 16392802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a potent, orally active pan-inhibitor of breakpoint cluster region-abelson (BCR-ABL) kinase including the T315I gatekeeper mutant.
    Huang WS; Metcalf CA; Sundaramoorthi R; Wang Y; Zou D; Thomas RM; Zhu X; Cai L; Wen D; Liu S; Romero J; Qi J; Chen I; Banda G; Lentini SP; Das S; Xu Q; Keats J; Wang F; Wardwell S; Ning Y; Snodgrass JT; Broudy MI; Russian K; Zhou T; Commodore L; Narasimhan NI; Mohemmad QK; Iuliucci J; Rivera VM; Dalgarno DC; Sawyer TK; Clackson T; Shakespeare WC
    J Med Chem; 2010 Jun; 53(12):4701-19. PubMed ID: 20513156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzothiazole carbamates and amides as antiproliferative species.
    Videnović M; Mojsin M; Stevanović M; Opsenica I; Srdić-Rajić T; Šolaja B
    Eur J Med Chem; 2018 Sep; 157():1096-1114. PubMed ID: 30179747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of benzothiazole derivatives bearing the ortho-hydroxy-N-acylhydrazone moiety as potent antitumor agents.
    Ma J; Zhang G; Han X; Bao G; Wang L; Zhai X; Gong P
    Arch Pharm (Weinheim); 2014 Dec; 347(12):936-49. PubMed ID: 25230149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C6-unsubstituted pyrazolo[3,4-d]pyrimidines are dual Src/Abl inhibitors effective against imatinib mesylate resistant chronic myeloid leukemia cell lines.
    Santucci MA; Corradi V; Mancini M; Manetti F; Radi M; Schenone S; Botta M
    ChemMedChem; 2009 Jan; 4(1):118-26. PubMed ID: 19039816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anticancer activity of (E)-2-benzothiazole hydrazones.
    Lindgren EB; de Brito MA; Vasconcelos TR; de Moraes MO; Montenegro RC; Yoneda JD; Leal KZ
    Eur J Med Chem; 2014 Oct; 86():12-6. PubMed ID: 25147145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual inhibition of Bcr-Abl and Hsp90 by C086 potently inhibits the proliferation of imatinib-resistant CML cells.
    Wu L; Yu J; Chen R; Liu Y; Lou L; Wu Y; Huang L; Fan Y; Gao P; Huang M; Wu Y; Chen Y; Xu J
    Clin Cancer Res; 2015 Feb; 21(4):833-43. PubMed ID: 25501124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxyamidotriazole inhibits cell growth of imatinib-resistant chronic myeloid leukaemia cells including T315I Bcr-Abl mutant by a redox-mediated mechanism.
    Corrado C; Raimondo S; Flugy AM; Fontana S; Santoro A; Stassi G; Marfia A; Iovino F; Arlinghaus R; Kohn EC; Leo GD; Alessandro R
    Cancer Lett; 2011 Jan; 300(2):205-14. PubMed ID: 21041018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative Evaluation of Some 2-[2-(2-Phenylethenyl)-cyclopent-3-en-1-yl]-1,3-benzothiazoles: DFT and Molecular Docking Study.
    Ceylan M; Erkan S; Yaglioglu AS; Akdogan Uremis N; Koç E
    Chem Biodivers; 2020 Apr; 17(4):e1900675. PubMed ID: 32141675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases.
    Gontarewicz A; Balabanov S; Keller G; Panse J; Schafhausen P; Bokemeyer C; Fiedler W; Moll J; Brümmendorf TH
    Leuk Res; 2008 Dec; 32(12):1857-65. PubMed ID: 18514829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis and antitumor activity of 5-substituted-2-(pyridyl)benzothiazole compounds].
    Liu WH; Chang JX; Liu Y
    Yao Xue Xue Bao; 2013 Jan; 48(1):83-8. PubMed ID: 23600146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and structure-activity relationships of novel benzothiazole derivatives bearing the ortho-hydroxy N-carbamoylhydrazone moiety as potent antitumor agents.
    Ma J; Chen D; Lu K; Wang L; Han X; Zhao Y; Gong P
    Eur J Med Chem; 2014 Oct; 86():257-69. PubMed ID: 25171780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.